Startup Companies across the Life Sciences Industry - Genetic TOE

USD 250.00

* Required Fields

USD 250.00


Be the first to review this product

This edition of Genetic Technology TOE profiles across startup companies across the life sciences industry. The corresponding patent scenario is also depicted along with industry interactions.The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants. The Health & Wellness cluster

Table of Contents

Startup Companies across the Life Sciences Industry - Genetic TOETechnology ProfilesDisease-causing Protein Degradation Using Proteolysis-targeting Chimeras Platform Drug Accelerators Enable the Development of Novel Therapeutics for Rare Diseases Developing Novel Small Molecule Solutions for Blood-based DisordersNon-opioid Pain Management Solutions for Treating Chronic PainAppendixPatent ScenarioPatent Scenario (continued)Industry Interactions

Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.